Carlsmed Inc

CARL USD0.00001
Create an alert
Sell
$13.87
Buy
$14.15
$0.21 (1.54%)
Last updated today at
Back to dashboard

Company Information

About this company

Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.

Key people

Michael Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Kevin K. Sidow
Independent Director
Philip Young
Independent Director
Niall Casey
Co-Founder, Director, Chief Intellectual Property Officer
Richard J. Heppenstall
Chief Financial Officer
Jeffrey Bertolini
Chief Operating Officer
William Durall
Chief Commercial Officer
Tony Jarc
Chief Product and AI Officer
Robert E. Mittendorff
Independent Director
Kevin C. O'Boyle
Independent Director
Jonathan D. Root
Independent Director
Click to see more

Key facts

  • Shares in issue
    27.34m
  • EPIC
    CARL
  • ISIN
    US14280C1053
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $366.13m
  • Employees
    127
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.